DC-Research Knowledge Portal: Clinical protocol for treatment advance prostate carcinoma w

has knowledgeable contact person

Daniela Rozková

Institute of Immunology 2nd Medical School, Charles University
Jirina Bartunkova

Scientific responsible

Institute of Immunology 2nd Medical School, Charles University

Protocols > Clinical protocol > Clinical protocol for treat...

Clinical protocol

The vaccine is composed by autologous DCs pulsed with apoptotic allogenic prostate carcinoma cell line LNCap.

Protocol Steps:

Vaccination of patients Patients with advanced prostate carcinoma are vaccinated with the DC vaccine.
Cell pulsing Autologous DC are pulsed with the apoptotic allogenic prostate carcinoma cell line LNCap to produce the vaccine for patients with advanced prostate carcinoma..

created over 15 years ago (2 March 2009) last modified over 13 years ago (28 September 2011) [ RDF ] [ RelFinder ]